X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1499) 1499
humans (1107) 1107
animals (705) 705
tissue inhibitor of metalloproteinase-3 - genetics (582) 582
female (579) 579
male (480) 480
tissue inhibitor (440) 440
mice (397) 397
matrix metalloproteinases (378) 378
expression (368) 368
tissue inhibitor of metalloproteinase-3 - metabolism (348) 348
middle aged (330) 330
gene expression (290) 290
adult (281) 281
cell biology (250) 250
biochemistry & molecular biology (242) 242
cells, cultured (241) 241
aged (237) 237
oncology (228) 228
research (192) 192
cancer (191) 191
research article (182) 182
proteins (180) 180
extracellular-matrix (179) 179
genetic aspects (173) 173
extracellular matrix (162) 162
apoptosis (161) 161
tissue inhibitor of metalloproteinase-1 - genetics (156) 156
matrix metalloproteinase (155) 155
in-vitro (152) 152
rna, messenger - metabolism (151) 151
analysis (150) 150
inflammation (149) 149
medicine (149) 149
cells (144) 144
reverse transcriptase polymerase chain reaction (141) 141
physiological aspects (139) 139
gene-expression (138) 138
immunohistochemistry (138) 138
rats (137) 137
multidisciplinary sciences (130) 130
cell line, tumor (126) 126
activation (123) 123
dna methylation (123) 123
tissue inhibitor of metalloproteinase-2 - genetics (120) 120
genes (118) 118
polymerase chain reaction (117) 117
abridged index medicus (116) 116
angiogenesis (115) 115
science (115) 115
tissue inhibitor of metalloproteinase-3 (115) 115
medicine, research & experimental (112) 112
genetics & heredity (111) 111
matrix metalloproteinase 3 - genetics (110) 110
rna, messenger - genetics (110) 110
timp-3 (110) 110
rodents (108) 108
development and progression (106) 106
metalloproteinase (106) 106
matrix metalloproteinases - metabolism (104) 104
collagen (103) 103
mice, inbred c57bl (103) 103
risk factors (102) 102
mutation (98) 98
health aspects (97) 97
matrix metalloproteinase 2 - metabolism (95) 95
messenger-rna (95) 95
signal transduction (95) 95
tissue inhibitor of metalloproteinase-1 - metabolism (95) 95
immunology (94) 94
enzymes (93) 93
article (92) 92
physiology (92) 92
cytokines (91) 91
disease models, animal (91) 91
metastasis (91) 91
case-control studies (90) 90
invasion (90) 90
matrix metalloproteinase 2 - genetics (90) 90
gene (89) 89
up-regulation (89) 89
pathology (88) 88
tissue inhibitor of metalloproteinases - genetics (88) 88
base sequence (87) 87
mice, knockout (86) 86
care and treatment (85) 85
gene expression regulation, neoplastic (85) 85
methylation (85) 85
matrix metalloproteinase 9 - metabolism (83) 83
molecular sequence data (83) 83
prognosis (83) 83
timp3 (83) 83
tissue inhibitors (83) 83
tumors (83) 83
aged, 80 and over (82) 82
down-regulation (81) 81
matrix metalloproteinase 3 - metabolism (80) 80
promoter regions, genetic (80) 80
stem cells (80) 80
biology (79) 79
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1599) 1599
Chinese (18) 18
Russian (3) 3
French (2) 2
German (1) 1
Polish (1) 1
Romanian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2018, Volume 13, Issue 4, pp. e0195116 - e0195116
Over expression of Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) in vascular smooth muscle cells (VSMCs) induces apoptosis and reduces neointima formation... 
MATRIX METALLOPROTEINASES | DEATH DOMAIN | OVEREXPRESSION | LEUKEMIC-CELLS | CD95 | INVASION | MECHANISM | REDISTRIBUTION | MULTIDISCIPLINARY SCIENCES | LIPID RAFTS | PROLIFERATION | Disintegrins - metabolism | Muscle, Smooth, Vascular - metabolism | Apoptosis - drug effects | Humans | Cells, Cultured | fas Receptor - antagonists & inhibitors | Membrane Potential, Mitochondrial - drug effects | Muscle, Smooth, Vascular - cytology | fas Receptor - metabolism | ADAM17 Protein - metabolism | Microscopy, Confocal | ADAM17 Protein - genetics | Caspases - metabolism | ADAM17 Protein - antagonists & inhibitors | RNA Interference | Tissue Inhibitor of Metalloproteinase-3 - metabolism | fas Receptor - genetics | Disintegrins - antagonists & inhibitors | CASP8 and FADD-Like Apoptosis Regulating Protein - metabolism | Staurosporine - pharmacology | RNA, Small Interfering - metabolism | Tissue Inhibitor of Metalloproteinase-3 - genetics | Medical research | Tumor necrosis factor | Physiological aspects | Medicine, Experimental | Research | Vascular smooth muscle | Health aspects | Apoptosis | Shedding | Immunoprecipitation | Smooth muscle | Lipids | Infections | Activation | Tissue inhibitor of metalloproteinase 3 | Caspase-3 | Cell surface | Proteins | Fas-associated protein | FADD protein | Signal transduction | Mitochondria | Rodents | FLIP protein | Interleukin 1 | Inhibition | Enzymes | ADAM protein | Cytokines | Mortality | Muscles | Caspase | c-FLIP protein | Clustering | Lymphoma | Caspase-8 | Signaling | Depletion | Overexpression | Inhibitors | Lymphocytes B | Adenoviruses | Caspase-9 | Death | Position (location) | Immunofluorescence | Cancer | B-cell lymphoma | Index Medicus
Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 06/2015, Volume 54, Issue 6, pp. 485 - 499
Aberrant epigenetic silencing of the tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) gene that negatively regulates matrix metalloproteinases (MMPs)... 
invasion | metastasis | green tea polyphenols | breast cancer | tissue inhibitors of matrix metalloproteinase‐3 | histone deacetylases | enhancer of zeste homolog 2 | Green tea polyphenols | Tissue inhibitors of matrix metalloproteinase-3 | Breast cancer | Metastasis | Enhancer of zeste homolog 2 | Histone deacetylases | Invasion | METHYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | tissue inhibitors of matrix metalloproteinase-3 | EPIGALLOCATECHIN-3-GALLATE EGCG | GENE | ONCOLOGY | PROSTATE-CANCER | ZESTE HOMOLOG-2 | TUMOR-GROWTH | EXPRESSION | CARCINOMA | Gene Silencing - drug effects | Humans | Polyphenols - pharmacology | Promoter Regions, Genetic - drug effects | Breast - metabolism | Breast Neoplasms - drug therapy | Acetylation - drug effects | Breast Neoplasms - genetics | Breast - drug effects | Breast Neoplasms - pathology | Polyphenols - chemistry | Cell Line, Tumor | Female | Catechin - analogs & derivatives | Epigenesis, Genetic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Catechin - pharmacology | Breast - pathology | DNA Methylation - drug effects | Catechin - chemistry | Tea - chemistry | Tissue Inhibitor of Metalloproteinase-3 - genetics | Epigenetic inheritance | RNA | Viral genetics | Analysis | Cancer cells | Polyphenols | Development and progression | Green tea | Epigenetics | Enzymes | Tea | Cells | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 9, pp. 1 - 13
Background: Tissue inhibitor of metalloproteinases-3 (TIMP-3) inhibits matrix metalloproteinases and membrane-bound sheddases. TIMP-3 is associated with the... 
PROGENITOR CELLS | COLONY-STIMULATING FACTOR | MATRIX-METALLOPROTEINASE | MULTIDISCIPLINARY SCIENCES | ALPHA-CONVERTING-ENZYME | NECROSIS-FACTOR-ALPHA | GROWTH-PROMOTING ACTIVITY | G-CSF | TUMOR-GROWTH | STEM-CELL MOBILIZATION | LONG BONES | Humans | Mice, Inbred C57BL | Male | Hematopoietic Stem Cells - metabolism | Animals | Hematopoiesis | Bone and Bones - metabolism | Hematopoietic Stem Cells - cytology | Tissue Inhibitor of Metalloproteinase-3 - metabolism | Mice | Osteogenesis | Bone and Bones - cytology | Tissue Inhibitor of Metalloproteinase-3 - genetics | B cells | T cells | Hematopoietic stem cells | Endothelium | Matrix metalloproteinases | Trafficking | Cytotoxicity | Tissue inhibitor of metalloproteinase 3 | Leukocytes | Osteoblasts | Blood | Proteins | Bone growth | Bone marrow | Biocompatibility | Spleen | Medical research | Enzymes | Myeloid cells | Cytokines | Forming | Overexpression | Inhibitors | Stromal cells | Stem cells | Ligands | Leukocytes (granulocytic) | Niches | Cell proliferation | Mesenchyme | Laboratories | Lymphocytes T | Remodeling | Tissues | Cell adhesion & migration | Biomedical materials | Granulocyte colony-stimulating factor | Lymphocytes | Rodents | Osteosclerosis | Tumor necrosis factor-TNF | Extracellular matrix | Colony-stimulating factor | Metalloproteinase | Colonies | Bone remodelling | Neutrophils | Hemopoiesis | White blood cells | Lymphocytes B | Cells (biology) | Bone | Hematopoietic system | Index Medicus
Journal Article
by Wei Chen and Dwight Stambolian and Albert O. Edwards and Kari E. Branham and Mohammad Othman and Johanna Jakobsdottir and Nirubol Tosakulwong and Margaret A. Pericak-Vance and Peter A. Campochiaro and Michael L. Klein and Perciliz L. Tan and Yvette P. Conley and Atsuhiro Kanda and Laura Kopplin and Yanming Li and Katherine J. Augustaitis and Athanasios J. Karoukis and William K. Scott and Anita Agarwal and Jaclyn L. Kovach and Stephen G. Schwartz and Eric A. Postel and Matthew Brooks and Keith H. Baratz and William L. Brown and Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group and Alexander J. Brucker and Anton Orlin and Gary Brown and Allen Ho and Carl Regillo and Larry Donoso and Lifeng Tian and Brian Kaderli and Dexter Hadley and Stephanie A. Hagstrom and Neal S. Peachey and Ronald Klein and Barbara E. K. Klein and Norimoto Gotoh and Kenji Yamashiro and Frederick Ferris and Jesen A. Fagerness and Robyn Reynolds and Lindsay A. Farrer and Ivana K. Kim and Joan W. Miller and Marta Cortón and Angel Carracedo and Manuel Sanchez-Salorio and Elizabeth W. Pugh and Kimberly F. Doheny and Maria Brion and Margaret M. DeAngelis and Daniel E. Weeks and Donald J. Zack and Emily Y. Chew and John R. Heckenlively and Nagahisa Yoshimura and Sudha K. Iyengar and Peter J. Francis and Nicholas Katsanis and Johanna M. Seddon and Jonathan L. Haines and Michael B. Gorin and Gonçalo R. Abecasis and Anand Swaroop and Mark T. Keating and Complications Age-Related Macular and Complications of Age-Related Macular Degeneration Prevention Trial Research Group and Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2010, Volume 107, Issue 16, pp. 7401 - 7406
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 143, Issue 5, pp. 1277 - 1287.e4
Background & Aims Tissue inhibitor of metalloproteinases (TIMP)-3 is an inhibitor of matrix metalloproteinases, which regulates tissue inflammation, damage,... 
Gastroenterology and Hepatology | ADAM | IBD | Ulcerative Colitis | Mouse Model | DIFFERENTIAL EXPRESSION | MACROPHAGES | ALPHA-CONVERTING-ENZYME | BOWEL-DISEASE | MATRIX METALLOPROTEINASES | TUMOR-NECROSIS-FACTOR | COLITIS | INSULIN-RESISTANCE | INDUCED ARTHRITIS | MICE | GASTROENTEROLOGY & HEPATOLOGY | Leukocytes, Mononuclear - metabolism | Intestinal Mucosa - metabolism | Colitis - genetics | Humans | Middle Aged | Tissue Inhibitor of Metalloproteinase-3 - pharmacology | Crohn Disease - metabolism | Trinitrobenzenesulfonic Acid | RNA, Messenger - metabolism | Intestinal Mucosa - drug effects | Gene Knockdown Techniques | Colitis - chemically induced | Tissue Inhibitor of Metalloproteinase-3 - metabolism | Adult | Smad7 Protein - genetics | Tissue Inhibitor of Metalloproteinase-3 - genetics | Leukocytes, Mononuclear - drug effects | Oligonucleotides, Antisense - pharmacology | Cytokines - metabolism | Colitis, Ulcerative - metabolism | Down-Regulation | Cells, Cultured | Mice, Transgenic | Gene Knockout Techniques | Mice, Knockout | Transforming Growth Factor beta - pharmacology | Amyloid Precursor Protein Secretases - metabolism | Animals | Colitis - metabolism | Aged | Mice | Enzymes | Epidermal growth factor | Analysis | Crohn's disease | Inflammation | Biological response modifiers | Ulcerative colitis | Tumors | Genetic engineering | T cells | Transforming growth factors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Blood, ISSN 0006-4971, 05/2012, Volume 119, Issue 20, pp. 4636 - 4644
Tissue inhibitor of metalloproteinase-3 (TIMP-3) is one of a family of proteins inhibiting matrix metalloproteinases, which has also been identified as a... 
IDIOPATHIC THROMBOCYTOPENIC PURPURA | IL-12 PRODUCTION | FUNCTIONAL DIVERSITY | IMMUNE-RESPONSES | LIPOPOLYSACCHARIDE | HEMATOLOGY | CANCER | EXPRESSION | CARCINOMA | T-CELLS | TIMP3 GENE | Purpura, Thrombocytopenic, Idiopathic - metabolism | Th1 Cells - physiology | Th2 Cells - physiology | Purpura, Thrombocytopenic, Idiopathic - genetics | Dendritic Cells - immunology | Humans | Middle Aged | Dendritic Cells - physiology | Male | Monocytes - metabolism | Th2 Cells - immunology | Th1 Cells - immunology | Tissue Inhibitor of Metalloproteinase-3 - antagonists & inhibitors | Th2 Cells - drug effects | Case-Control Studies | Purpura, Thrombocytopenic, Idiopathic - blood | Young Adult | Cell Differentiation - genetics | Purpura, Thrombocytopenic, Idiopathic - immunology | Tissue Inhibitor of Metalloproteinase-3 - metabolism | Adult | Dendritic Cells - drug effects | Female | Cell Polarity - drug effects | Monocytes - physiology | Tissue Inhibitor of Metalloproteinase-3 - genetics | Cell Polarity - immunology | Th1 Cells - drug effects | RNA, Small Interfering - pharmacology | Cells, Cultured | Th2 Cells - cytology | Tissue Inhibitor of Metalloproteinase-3 - physiology | Monocytes - drug effects | Cell Differentiation - immunology | Cell Polarity - genetics | Cell Differentiation - drug effects | Adolescent | Th1 Cells - cytology | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 01/2002, Volume 105, Issue 4, pp. 477 - 482
Journal Article
Cell Reports, ISSN 2211-1247, 09/2012, Volume 2, Issue 3, pp. 568 - 579
Journal Article